The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A
Authors:
- 21 April 2009
- journal article
- Published by Wiley in Haemophilia
- Vol. 15 (3) , 828-830
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- New assays for monitoring haemophilia treatmentHaemophilia, 2008
- Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis RegisterInternal Medicine Journal, 2007
- Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life‐threatening massive bleeding in a patient with haemophilia A and a high responding inhibitorHaemophilia, 2004
- Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitorsHaemophilia, 2004